Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction

Myungsoo Joo1, Young S Hahn, Minjae Kwon

  • 1Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2650, USA. myungsoo.joo@vanderbilt.edu

Journal of Virology
|May 28, 2005
PubMed

Insights

Hepatitis C virus (HCV) core protein disrupts immune cell function by inhibiting NF-kappaB activation and cyclooxygenase-2 (COX-2) expression in macrophages, potentially impacting HCV pathogenesis.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) infects hepatocytes and immune cells like macrophages.
  • The impact of HCV on macrophage function is not well understood.
  • Lipopolysaccharide (LPS) activates the IKK/NF-kappaB pathway, inducing cyclooxygenase-2 (COX-2) and prostaglandin production, key inflammatory mediators.

Purpose of the Study:

  • To investigate if HCV core protein interferes with IKK signalsome activity and COX-2 expression in activated macrophages.
  • To elucidate the molecular mechanisms by which HCV might modulate immune responses in macrophages.

Main Methods:

  • Reporter assays in RAW 264.7 and MH-S murine macrophage cell lines treated with LPS.
  • Analysis of IKK signalsome and IKKbeta kinase activities in HeLa and 293 cells.
  • Co-precipitation assays to assess interactions between HCV core and IKKbeta.
  • Western blotting to evaluate COX-2 expression levels.

Main Results:

  • HCV core inhibited NF-kappaB activation induced by LPS in macrophage cell lines.
  • HCV core suppressed IKK signalsome and IKKbeta kinase activities.
  • HCV core interacted with IKKbeta and prevented its nuclear translocation.
  • Ectopic expression of HCV core markedly suppressed LPS- or IKKbeta-induced COX-2 expression.

Conclusions:

  • HCV core protein suppresses IKK signalsome activity in macrophages.
  • This suppression leads to blunted COX-2 expression, potentially affecting inflammatory responses.
  • Further research is needed to determine the role of disrupted COX-2 expression in HCV pathogenesis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...